Shrink down, margins up at Dollar General a year after removing nearly all self-checkout
This story was originally published on Retail Dive. To receive daily news and insights, subscribe to our free daily Retail Dive newsletter.
A year after its move to take out most of its self-checkout, Dollar General reported that lower shrink and higher inventory markup were major factors in boosting Q1 gross margin by 78 basis points to 31%. Net income rose nearly 8% to $392 million.
Net sales in the period rose 5.3% year over year to $10.4 billion. Despite a 0.3% traffic decline, comps rose 2.4%, thanks to a 2.7% bump in average transaction amount, the discounter said Tuesday.
In Q1, Dollar General opened 156 stores, remodeled 668 as part of Project Elevate and 559 as part of Project Renovate. The company, which as of May 2 runs more than 20,000 locations, aims to overhaul 20% of its fleet each year, CEO Todd Vasos told analysts Tuesday. Plans for 2025 include opening about 575 stores in the U.S. and up to 15 in Mexico and remodeling about 4,250.
Not long ago, shrink was an obsession of major retail industry groups and some major chains, though visibility into the issue has decreased since the National Retail Federation stopped publishing its shrink report. A year ago Vasos called shrink 'the most significant headwind in our business.'
But on Tuesday, Dollar General Chief Financial Officer Kelly Dilts told analysts that improvement in shrink rates will be a tailwind throughout the year and that 'should be the gift that just keeps on giving here.'
'As we think about gross margin, we are just really pleased with where shrink came in,' she said.
Major changes to Dollar General stores have entailed not just pulling self-checkout kiosks from stores but also improving layout, merchandising and staffing.
'Our store standards are much, much better than they've been in quite a long time, and every single quarter that goes by continues to get better and better,' Vasos said Tuesday.
That is backed up by GlobalData channel checks, which found that fewer Dollar General locations suffer from inferior standards. 'While there are still some issues like cages and boxes cluttering up aisles, Dollar General seems to have minimized this issue with better scheduling and a modest investment in labor,' GlobalData Managing Director Neil Saunders said in emailed comments.
Tariffs and the economy are likely to be the big challenges looming over Dollar General's performance, according to Saunders.
Direct imports are 'a relatively small percentage' of Dollar General's business and tend to be in the mid- to high-single digit range of its overall purchases, with indirect imports varying, Vasos said. The company has diversified its supply chain — reducing its direct imports from China to less than 70% and indirect imports from China to less than 40% — and worked with vendors to share costs and found substitute merchandise where possible.
However, raising some prices may be inevitable.
'While the tariff landscape remains dynamic and uncertain, we expect tariffs to result in some price increases as a last resort, though we intend to work to minimize them as much as possible,' Vasos said. 'In turn, we believe our customers will continue to seek opportunities to save money, and we remain committed to serving them with the everyday low prices they have come to know and appreciate from Dollar General.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
‘Dupixent-fuelled' atopic dermatitis market sales to hit $22.4bn by 2033
The global atopic dermatitis (AD) market is poised to reach $22.4bn in drug sales within the decade, buoyed by the availability of targeted therapies, market analysis suggests. A 2025 report published by GlobalData, which analysed the seven major markets of the US, UK, France, Germany, Italy, Spain, and Japan, forecasts sector sales will reach the $22.4bn figure by 2033, up from $8.5bn in 2023, reflecting a compound annual growth rate (CAGR) of 10.2%. While not as fast-growing as the weight loss market in the metabolic disease space, the AD market growth is salient given the market's size compared to other dermatology indications. GlobalData healthcare analyst, Filippos Maniatis, comments: 'AD is a growing market with an impressive pipeline of new products from current and future players in the field. The AD space was previously dominated by broad-acting immunomodulatory agents, which are now being slowly replaced by more targeted agents. This shift is likely due to better comprehension of the pathophysiology behind AD and the approval of several new systemic agents.' GlobalData is the parent company of Pharmaceutical Technology. One of those targeted agents that has taken the market by storm is Regeneron and Sanofi's jointly developed Dupixent (dupilumab), first approved in the US in 2017. The blockbuster monoclonal antibody has seen its sales increase year-over-year amid high uptake from AD – reaching $14.9bn in sales in 2024. Dupixent is approved for a range of diseases, including a lucrative asthma indication. The report says that the gap of unmet need in AD, which is closing courtesy of Sanofi and Regeneron, is set to shrink even further depending on future approvals for more targeted therapies. One modality poised as a future disruptor is the OX40 inhibitor class of drugs that work by inhibiting T-cell activation and inflammation via the OX40 receptor on the immune cells. Pipeline candidates in development include Amgen and Kyowa Kirin's rocatinlimab, Sanofi's amlitelimab, and Astria Therapeutics' telazrolimab. Another class with a potential future in AD is interleukin (IL) inhibitors. LEO Pharma, GSK, and Nektar all have assets in clinical development. Maniatis concludes: 'With multiple pipeline agents in development, key unmet needs may be further addressed. Such unmet needs include the lack of personalised treatments through improved diagnostic methods, the high cost of current therapy options, the limited therapeutic options for chronic hand eczema, and better long-term disease control and management.' "'Dupixent-fuelled' atopic dermatitis market sales to hit $22.4bn by 2033" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
2 hours ago
- Yahoo
Banking Excellence special report 2025: Asia Pacific charts an AI-ready course
First off, the warmest of congratulations to all of the winners at the 16th annual Retail Banker International Asia Trailblazer Awards. The special report setting out who won what and why is available via this link. Once again, it is gratifying to note the huge number of institutions that participated this year. But, arguably, the biggest takeaway of these awards is the quality of the entries. It will have been very obvious to all of the judges that the participating financial institutions paid a massive amount of attention to detail when crafting their submissions. These awards serve to showcase leaders in the Asia Pacific financial services sector and the winners are to be commended and celebrated for their world-class levels of innovation. As many of the nations in the region accelerate efforts to diversify away from oil and other natural resources, the banking, payments, fintech and alternative digital providers are punching above their weight to lift technology standards to global levels and beyond. It is notable that the region's incumbent banks and the increasing number of digital challengers are well placed to tap into the growing popularity of digital wallets and e-commerce, as cash displacement starts to gather speed. Looking ahead, it is gratifying to note the levels of enthusiasm and determination in the sector to optimise the opportunities that the shift towards AI and advanced technologies presents. In all markets, there is a growing appreciation of the fact that businesses face a hard choice between being left behind or being part of this technological disruption. I am optimistic the tech-savvy financial services providers in the region will grab the opportunities that AI and advanced technologies will offer. And as always, a massive well done and thank you to the judges and my GlobalData colleagues at our MEED division. Administering the annual awards, receiving entries and conducting the judging process is a Herculean task. Hearty congratulations again to all of the winners and here's to the 17th Annual Retail Banker International – Asia Trailblazer Awards to be held in Singapore on 12 March 2026. "Banking Excellence special report 2025: Asia Pacific charts an AI-ready course" was originally created and published by Retail Banker International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Paychex launches Partner Pro portal for accountants
Paychex, a human capital management company, has announced the launch of its new Paychex Partner Pro portal, for accountants. This platform is designed to provide accountants with access to essential client data, reporting, and insights, specifically for business clients utilising Paychex Flex. The Paychex Partner Pro portal is said to redefine how accountants manage their book of business by offering proactive insights in a centralised view. This enhancement is expected to streamline workflows and bolster client advisory services. Paychex vice president and general manager, HCM solutions – small market, Ted Jordan said: 'Paychex Partner Pro provides a clear view into some of the most critical aspects of today's accounting operations, including aggregated client payroll and HR information, the ability to address outstanding issues, and, most importantly, identifying missing information that could help reduce potential penalties.' 'These enhanced features ensure accountants have the tools they need to be more efficient and proactive for their clients.' Jordan continued: 'Paychex Partner Pro reinforces our long-standing commitment to improving the accountant experience through continuous innovation based on user needs and industry trends.' Accountants who were earlier using Paychex's AccountantHQ now have the ability to access the full range of Paychex Flex functionality through an 'intuitive' dashboard that mirrors the client experience. Key features of the Paychex Partner Pro portal include client search capabilities, with the option to pin up to five clients for access to important details. It is also said to provides insights to help accountants identify clients with missing tax IDs, social security numbers, or those who have missed payroll dates, thereby staying ahead of potential issues. Additionally, the portal offers access to a dedicated hub filled with 'advanced and relevant' customer-specific insights. Paychex is set to showcase the Paychex Partner Pro portal at the upcoming AICPA & CIMA Engage 25 conference in Las Vegas, to be held from 9-12 June. Attendees can experience a hands-on demonstration of the portal at the Paychex booth on the expo hall floor. In addition, Paychex will conduct in-person educational sessions during the conference that are eligible for continuing professional education credits. "Paychex launches Partner Pro portal for accountants" was originally created and published by International Accounting Bulletin, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data